August 11th 2025
NRx Pharmaceuticals secures FDA Fast Track designation for NRX-100, a preservation-free formulation of intravenous ketamine for suicidal ideation in depression.
Insights From the 2022 AAPL Annual Meeting
The American Academy of Psychiatry and the Law hosted its first in-person meeting in October 2022. Check out these highlights.
Read More
Lithium and Suicide Prevention: More Thoughts on Recent VA Study
October 14th 2022"Despite this new study and the need for further research, the best recommendation at this time regarding lithium in patients with bipolar disorder who are suicidal would be to consider it a worthwhile option."
Read More